Detailed analysis of food-reinforced operant lever pressing distinguishes effects of a cannabinoid CB1 inverse agonist and dopamine D1 and D2 antagonists

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 1, 2010, Pages 75-81

  McLaughlin, P J ^a   Winston, K M ^a   Swezey, L A ^a   Vemuri, V K ^b   Makriyannis, A ^b   Salamone, J D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Appetite; Cannabinoid; Fixed ratio; Microanalysis; Motivation; Operant conditioning; Rimonabant

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; CANNABINOID 1 RECEPTOR AGONIST; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; REACTION TIME; REINFORCEMENT;

ANIMALS; CANNABINOIDS; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INVERSE AGONISM; FEEDING BEHAVIOR; FOOD; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE;

RATTUS;

EID: 77953287252     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.009     Document Type: Article

References (58)

1. Arnone M., Maruani J., Chaperon F., Thiébot M.-H., Poncelet M., Soubrié P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 1997, 132(1):104-106.
2. Barbano M.F., Le Saux M., Cador M. Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology (Berl) 2009, 203(3):475-487.
3. Carriero D., Aberman J., Lin S.Y., Hill A., Makriyannis A., Salamone J.D. A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing. Psychopharmacology (Berl) 1998, 137(2):147-156.
4. Chambers A.P., Koopmans H.S., Pittman Q.J., Sharkey K.A. AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion. Br J Pharmacol 2006, 147(1):109-116.
5. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 1998, 63(8):113-117.
6. Farrar A.M., Pereira M., Velasco F., Hockemeyer J., Muller C.E., Salamone J.D. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing. Psychopharmacology (Berl) 2007, 191(3):579-586.
7. Freedland C.S., Poston J.S., Porrino L.J. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 2000, 67(2):265-270.
8. Freedland C.S., Whitlow C.T., Smith H.R., Porrino L.J. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naïve and -tolerant animals: a quantitative 2-[14C]deoxyglucose study. Brain Res 2003, 962(1-2):169-179.
9. Fowler S.C., Liao J.R. Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not. Psychopharmacology (Berl) 1998, 140(1):81-90.
10. 123I-labeled AM 251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 1996, 307(3):331-338.
11. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., et al. Cannabinoid receptor localization in brain. Proc Nat Acad Sci USA 1990, 87(5):1932-1936.
12. Herkenham M., Lynn A.B., de Costa B.R., Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 1991, 547(2):267-274.
13. Hermann H., Marsicano G., Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 2002, 109(3):451-460.
14. Higgs S., Williams C.M., Kirkham T.C. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 2003, 165(4):370-377.
15. Hodge J., Bow J.P., Plyler K.S., Vemuri V.K., Wisniecki A., Salamone J.D., et al. The cannabinoid CB1 receptor inverse agonist and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats. Behav Brain Res 2008, 193(2):298-305.
16. Institute of Laboratory Animal Resources Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, DC.
17. Keppel G., Wickens T.D. Design and analysis: a researcher's handbook 2004, Prentice-Hall, Englewood Cliffs, NJ. 4th Ed.
18. Killeen P.R. Mathematical principles of reinforcement. Behav Brain Sci 1994, 17(1):105-172.
19. Lowe C.F., Davey G.C., Harzem P. Effects of reinforcement magnitude on interval and ratio schedules. J Exp Anal Behav 1974, 22(3):553-560.
20. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., et al. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 1991, 40(3):471-478.
21. McLaughlin P.J., Delevan C.E., Carnicom S., Robinson J.K., Brener J. Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol. Pharmacol Biochem Behav 2000, 66(4):803-809.
22. McLaughlin P.J., Winston K., Swezey L., Wisniecki A., Aberman J., Tardif D.J., et al. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 2003, 14(8):583-588.
23. McLaughlin P.J., Winston K.M., Limebeer C.L., Parker L.A., Makriyannis A., Salamone J.D. The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. Psychopharmacology (Berl) 2005, 180(2):286-293.
24. McLaughlin P.J., Lu D., Winston K.M., Thakur G., Swezey L.A., Makriyannis A., et al. Behavioral effects of the novel cannabinoid full agonist AM 411. Pharmacol Biochem Behav 2005, 81(1):78-88.
25. McLaughlin P.J., Qian L., Wood J.T., Wisniecki A., Winston K.M., Swezey L.A., et al. Suppression of food intake and food-reinforced behavior produced by the novel CB1 receptor antagonist/inverse agonist AM 1387. Pharmacol Biochem Behav 2006, 83(3):396-402.
26. Melis T., Succu S., Sanna F., Boi A., Argiolas A., Melis M.R. The cannabinoid antagonist SR 141716A (rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett 2007, 419(3):231-235.
27. Merroun I., Errami E., Hoddah H., Urbano G., Porres J.M., Aranda P., Llopis J., Lopez-Jurado M. Influence of intracerebroventricular or intraperitoneal administration of cannabinoid receptor agonist (WIN 55,212-2) and inverse agonist (AM 251) on the regulation of food intake and hypothalamic serotonin levels. BR J Nutr 2009, 101(10):1569-1578.
28. Mingote S., Weber S.M., Ishiwari K., Correa M., Salamone J.D. Ratio and time requirements on operant schedules: effort-related effects of nucleus accumbens dopamine depletions. Eur J Neurosci 2005, 21(6):1749-1757.
29. Mingote S., Font L., Farrar A.M., Vontell R., Worden L.T., Stopper C.M., et al. Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway. J Neurosci 2008, 28(36):9037-9046.
30. Mobini S., Chiang T.J., Ho M.Y., Bradshaw C.M., Szabade E. Comparison of the effects of clozapine, haloperidol, chlorpromazine, and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology (Berl) 2000, 152(1):47-54.
31. Need A.B., Davis R.J., Alexander-Chacko J.T., Eastwood B., Chernet E., Phebus L.A., et al. The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats. Psychopharmacology (Berl) 2006, 184(1):26-35.
32. Niv Y., Daw N.D., Joel D., Dayan P. Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) 2007, 191(3):507-520.
33. Nowend K.L., Arizzi M., Carlson B.B., Salamone J.D. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 2001, 69(3-4):373-382.
34. Pério A., Barnouin M.C., Poncelet M., Soubrié P. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats. Behav Pharmacol 2001, 12(8):641-645.
35. Pickel V.M., Chan J., Kearn C.S., Mackie K. Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. Comp Neurol 2006, 495(3):299-313.
36. Powell R.W. The effect of reinforcement magnitude upon responding under fixed-ratio schedules. J Exp Anal Behav 1969, 12(4):605-608.
37. Raudenbush S.W., Gleser L., Hedges L., Johnson E., Petkova E. Comparing regression coefficients between models: concepts and illustrative examples 1997, National Institute of Statistical Sciences, Technical Report No. 65.
38. Rick J.H., Horvitz J.C., Balsam P.D. Dopamine receptor blockade and extinction differentially affect behavioral variability. Behav Neurosci 2006, 120(2):488-492.
39. Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994, 350(2-3):240-244.
40. Rusk I.N., Cooper S.J. Parametric studies of selective D1 or D2 antagonists: effects on appetitive and feeding behaviour. Behav Pharmacol 1994, 5(6):615-622.
41. Salamone J.D., Zigmond M.J., Stricker E.M. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience 1990, 39(1):17-24.
42. Salamone J.D., Steinpreis R.E., McCullough L.D., Smith P., Grebel D., Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food-choice procedure. Psychopharmacology (Berl) 1991, 104(4):515-521.
43. Salamone J.D., Mahan K., Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol Biochem Behav 1993, 44(3):605-610.
44. Salamone J.D., Kurth P.A., McCullough L.D., Sokolowski J.D., Cousins M.S. The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res 1993, 628(1-2):218-226.
45. Salamone J.D., Kurth P., McCullough L.D., Sokolowski J.D. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: contrasts with the effects of extinction. Pharmacol Biochem Behav 1995, 50(3):437-443.
46. Salamone J.D., Cousins M.S., Maio C., Champion M., Turski T., Kovach J. Different behavioral effects of haloperidol, clozapine and thioridazine in an instrumental lever pressing/feeding procedure. Psychopharmacology (Berl) 1996, 125(2):105-112.
47. Salamone J.D., Aberman J.E., Sokolowski J.D., Cousins M.S. Nucleus accumbens dopamine and rate of responding: neurochemical and behavioral studies. Psychobiology 1999, 27(2):236-247.
48. Salamone J.D., Arizzi M.N., Sandoval M.D., Cervone K.M., Aberman J.E. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride and fenfluramine on a concurrent choice task. Psychopharmacology (Berl) 2002, 160(4):371-380.
49. Sink K.S., Vemuri V.K., Olszewska T., Makriyannis A., Salamone J.D. Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology (Berl) 2008, 196(4):565-574.
50. Skjoldager P., Winger G., Woods J.H. Analysis of fixed-ratio behavior maintained by drug reinforcers. J Exp Anal Behav 1991, 56(2):331-343.
51. Tallett A.J., Blundell J.E., Rodgers R.J. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation. Behav Pharmacol 2007, 18(7):591-600.
52. Tallett A.J., Blundell J.E., Rodgers R.J. Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching. Physiol Behav 2008, 94(3):422-431.
53. Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276(5321):2048-2050.
54. Trevitt J., Atherton A., Aberman J., Salamone J.D. Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat. Psychopharmacology (Berl) 1998, 137(1):61-66.
55. Varvel S.A., Vann R.E., Wise L.E., Philibin S.D., Porter J.H. Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology (Berl) 2002, 160(2):182-191.
56. Ward S.J., Dykstra L.A. The role of CB1 receptors in sweet vs. fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol 2005, 16(5-6):381-388.
57. Wiley J.L., Martin B.R. Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 2003, 471(3):185-193.
58. Xi Z.X., Gilbert J.G., Peng X.Q., Pak A.C., Li X., Gardner E.L. Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in teh nucleus accumberns. J Neurosci 2006, 26(33):8531-8536.